{"id":"W4287730147","doi":"10.1016/s1470-2045(22)00139-5","title":"Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup","year":2022,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"Daiichi Sankyo Europe; National Cancer Institute; Chugai Pharmaceutical; Genentech; National Institutes of Health; Mereo BioPharma; Medac; PharmaMar; Eisai; Seagen; Verastem Oncology; Pfizer; NuCana; Incyte; National Medical Research Council; Karyopharm Therapeutics; Kissei; National Institute for Health and Care Research; Clovis Oncology; Nippon Shinyaku; AstraZeneca; Novocure; Mersana Therapeutics; Amgen; Deciphera Pharmaceuticals; Medical Research Council; Teva Pharmaceutical Industries; Fuji Pharma; GlaxoSmithKline; European Commission; PTC Therapeutics; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Consensus conference; Concordance; Ovarian cancer; Medicine; Clinical trial; Deliberation; Gynecologic cancer; Family medicine; Clinical research; MEDLINE; Gynecology; Cancer; Oncology; Internal medicine; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04995599,0.002561011,0.008926347,0.01189722,0.001450093,0.007434676,0.006903407,0.01039116,0.005779663],"category_scores_gemma":[0.05624937,0.001481366,0.007347019,0.01142172,0.002147885,0.005113899,0.005835483,0.01190203,0.003000609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008828125,"about_ca_system_score_gemma":0.03741724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01343145,"about_ca_topic_score_gemma":0.02306647,"domain_scores_codex":[0.9830898,0.005225309,0.004861723,0.001421662,0.004468182,0.0009332487],"domain_scores_gemma":[0.9400166,0.03697893,0.006572005,0.001014809,0.01229547,0.003122296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006771314,0.0001020882,0.0005625388,0.1857502,0.002294893,0.0001532248,0.0003365215,0.0006029684,0.0005813166,0.006799298,0.2325051,0.5696348],"study_design_scores_gemma":[0.0007806054,0.0001435986,0.001778344,0.2652115,0.005371476,0.0002069679,0.0002619858,0.0001983836,0.0002283046,0.007005849,0.7187268,0.00008605002],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007226865,0.9727482,0.0005117784,0.02013309,0.004683703,0.0002194035,0.000358484,0.00003331112,0.001239822],"genre_scores_gemma":[0.0009370441,0.9797507,0.00278341,0.01320259,0.001832201,0.0003709538,0.0004447501,0.00002193679,0.000656392],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04995599,"threshold_uncertainty_score":0.2641957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5870445998710079,"score_gpt":0.5953735657196614,"score_spread":0.008328965848653502,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}